| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | — | +106.9% |
| Cost of Revenue | $2.5M | — | +600.6% |
| R&D Expense | $3.9M | — | +36.1% |
| SG&A Expense | $6.9M | — | +63.8% |
| Operating Income | -$11.9M | — | -72.0% |
| Pre-tax Income | -$12.6M | — | -155.4% |
| Income Tax | $0 | — | — |
| Net Income | -$12.6M | — | -155.4% |
| EPS (Basic) | -$0.28 | — | -143.8% |
| EPS (Diluted) | -$0.28 | — | -150.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.9M | -2.0% | +77.5% |
| Short-term Investments | $25.8M | -10.4% | -29.4% |
| Accounts Receivable | $1.6M | +51.0% | +895.6% |
| Inventory | $989K | +191.7% | +1254.8% |
| Current Assets | $50.3M | -4.2% | +0.2% |
| Total Assets | $92.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.2M | — | -36.2% |
| Capital Expenditures | $27K | — | -71.0% |
| Investing Cash Flow | $3.3M | — | +112.0% |
| Financing Cash Flow | $6.6M | — | -52.9% |
| Free Cash Flow | -$10.3M | — | -34.9% |
| +46.2% |
| Current Liabilities | $6.4M | +13.3% | +104.6% |
| Total Liabilities | $22.6M | +7.6% | -35.3% |
| Stockholders' Equity | $69.9M | -6.4% | +147.1% |